Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy

98Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty-one ambulatory subjects with DMD (mean age 8.9 years; range 5-16 years) were evaluated at eight sites by 15 newly trained evaluators as a test of interrater reliability of outcome measures. Both total QMT score [intraclass correlation coefficient (ICC) 0.96] and individual QMT assessments (ICC 0.85-0.96) were highly reliable. Forced vital capacity and all timed function tests were also highly reliable (ICC 0.97-0.99). MMT was the least reliable assessment method (ICC 0.61). These data suggest that primary surrogate outcome measures in large multicenter clinical trials in DMD should use QMT, FVC, or time function tests to obtain maximum power and greatest sensitivity. © 2006 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Mayhew, J. E., Florence, J. M., Mayhew, T. P., Henricson, E. K., Leshner, R. T., McCarter, R. J., & Escolar, D. M. (2007). Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle and Nerve, 35(1), 36–42. https://doi.org/10.1002/mus.20654

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free